Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-22-012483
Filing Date
2022-04-01
Accepted
2022-04-01 08:01:14
Documents
6
Effectiveness Date
2022-04-01

Document Format Files

Seq Description Document Type Size
1 S-8 brhc10035847_s8.htm S-8 25848
2 EXHIBIT 5.1 brhc10035847_ex5-1.htm EX-5.1 6477
3 EXHIBIT 23.1 brhc10035847_ex23-1.htm EX-23.1 2250
4 EXHIBIT 24 brhc10035847_ex24.htm EX-24 16850
5 EXHIBIT 107 brhc10035847_ex107.htm EX-FILING FEES 13672
6 image00004.jpg GRAPHIC 86120
  Complete submission text file 0001140361-22-012483.txt   184869
Mailing Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932
Business Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

EIN.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-264048 | Film No.: 22795852
SIC: 2834 Pharmaceutical Preparations